MedPath

Presbyopia-Correcting Intraocular Lenses (IOLs)

Phase 4
Completed
Conditions
Cataract
Interventions
Device: ReSTOR +3
Device: Crystalens HD
Device: Crystalens AO
Registration Number
NCT00963560
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to prospectively evaluate postoperative visual and refractive parameters in a series of subjects bilaterally implanted with Presbyopia-Correcting Intraocular Lenses (IOLs).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
132
Inclusion Criteria
  • diagnosed with bilateral cataracts
  • candidate for presbyopic lens
Read More
Exclusion Criteria
  • > 1 Diopter preoperative astigmatism by Keratometry readings
  • pre-existing conditions that could skew the results
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ReSTOR +3ReSTOR +3Bilateral implantation of ReSTOR +3 Intraocular Lens (IOL)
Crystalens HDCrystalens HDBilateral implantation of Crystalens HD Intraocular Lens (IOL)
Crystalens AOCrystalens AOBilateral implantation of Crystalens AO Intraocular Lens (IOL)
Primary Outcome Measures
NameTimeMethod
Best Corrected Visual Acuity6 Months after surgery

Best corrected vision was tested at 4 meters (m), 60 centimeters (cm), 40cm and at preferred distance (distance chosen by each subject) with a standard ETDRS chart for distance and a hand held chart for near. Scores were calculated using logMAR values. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better visual acuity. Preferred distance for each study group was as follows: ReSTOR +3 = 38.7 +/- 6.8 cm, Crystalens HD = 49.9 +/- 9.8 cm, Crystalens AO = 53.1 +/- 9.8 cm.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Contact Alcon Call Center For Trial Locations

🇺🇸

Fort Worth, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath